Author Correction: Meta-analyses of sulodexide and other drugs in prevention and treatment of post-thrombotic syndrome

G. Pompilio, M. Monreal, R. Pesavento, D. Integlia

ISHEO S.r.l., Rome, Italy

---

• Vascular Medicine

Correction to: Eur Rev Med Pharmacol Sci 2022; 26 (24): 9372-9381. DOI: 10.26355/eurrev_202212_30688-PMID: 36591846-published online on December 21, 2022.

After publication, the authors found a typo in the discussion section. The sentence to amend is the following one:

·       In meta-analyses of observational studies, we found a low incidence of PTS, with 9% of patients presenting PTS among patients receiving sulodexide and a 50% reduction in the risk of PTS in patients receiving rivaroxaban.

The “9%” in the sentence below should be changed to “15%” (in order to align the Discussion section with the Results section and the Abstract.

There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause.

Meta-analyses of sulodexide and other drugs in prevention and treatment of post-thrombotic syndrome

 

Free PDF Download